Andrew I Koven has an estimated net worth of $6.97 Million. This is based on reported shares across multiple companies, which include NEUROLOGIX INC/DE, NeuroBo Pharmaceuticals, Inc., KALA BIO, Inc., Aralez Pharmaceuticals Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, SEPRACOR INC /DE/, KOS PHARMACEUTICALS INC, and INSPIRE PHARMACEUTICALS INC.
2014 was Andrew I Koven's most active year for acquiring shares with 8 total transactions. Andrew I Koven's most active month to acquire stocks was the month of May. 2005 was Andrew I Koven's most active year for disposing of shares, totalling 8 transactions. Andrew I Koven's most active month to dispose stocks was the month of April. 2007 saw Andrew I Koven paying a total of $4,947,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2015 Andrew I Koven cashed out on 232,446 shares for a total of $8,491,252.38, their largest year based on trade value.